Effects on DNA integrity and apoptosis induction by a novel antitumor sesquiterpene drug, 6-hydroxymethylacylfulvene (HMAF, MGI 114)

Biochemical Pharmacology
J M WoynarowskiJ R MacDonald

Abstract

6-Hydroxymethylacylfulvene (HMAF, MGI 114) is a new alkylating antitumor sesquiterpenoid with promising and often curative antitumor activity in vivo. This study examined the ability of the drug to damage cellular DNA, induce apoptosis, and affect the cell cycle of CEM human leukemia cells. No bifunctional lesions, interstrand DNA cross-links or DNA-protein cross-links were seen (by alkaline sedimentation and K+/SDS precipitation, respectively) when using up to 50 microM HMAF. The drug possibly formed some monoadducts, as DNA from drug-treated cells impeded primer extension by Taq polymerase, although only partial inhibition was seen even at 200 microM HMAF. HMAF also induced secondary lesions in cellular DNA, single-strand breaks that were detectable (by nucleoid sedimentation and alkaline sucrose gradient analysis) after a 4-hr treatment at HMAF levels as low as 2 microM, comparable to the growth inhibition IC50 value (1.7 microM). A post-treatment incubation of cells in drug-free medium generated substantial amounts of DNA double-stranded fragments of several kbp, suggesting apoptotic fragmentation (>30% of total DNA following treatment with 20 microM HMAF and a 17-hr post-treatment incubation). Chromatin condensation (by ul...Continue Reading

References

Jan 1, 1992·Cytometry·Z DarzynkiewiczF Traganos
Sep 30, 1992·Biochemical and Biophysical Research Communications·D BarbieriC Franceschi
Nov 1, 1990·Chemical Research in Toxicology·T C McMorrisR Taetle
Oct 3, 1990·Journal of the National Cancer Institute·M J KelnerR Taetle
Nov 20, 1987·Biochimica Et Biophysica Acta·J M WoynarowskiT A Beerman
Dec 1, 1987·The Journal of Pathology·A H Wyllie
Nov 1, 1994·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·M CejnaW Bursch
Aug 3, 1993·Biochemical Pharmacology·A Skladanowski, J Konopa
Aug 30, 1994·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J A HickmanT C Fisher
Apr 15, 1994·Cancer·J F KerrB V Harmon
Nov 1, 1993·Journal of Cellular Physiology·J GongZ Darzynkiewicz
Aug 1, 1993·Anti-cancer Drugs·S F ChenJ B Jiang
Sep 1, 1996·Journal of Natural Products·T C McMorrisR Taetle

❮ Previous
Next ❯

Citations

Mar 26, 2004·Cancer Chemotherapy and Pharmacology·Rama S RangaDamodaran Chendil
Oct 27, 2004·Cancer Chemotherapy and Pharmacology·Michael H WooPeter J Houghton
Feb 19, 1999·Biochimica Et Biophysica Acta·J M WoynarowskiM C Herzig
Nov 30, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L A HammondS Weitman
Nov 6, 2003·Clinical Lung Cancer·Mary Hightower, Jennifer Klem
Apr 10, 2012·Chemical Reviews·Marina Tanasova, Shana J Sturla
Nov 3, 2005·Journal of the American Chemical Society·Ken S Feldman, Kyle J Eastman
Nov 27, 2009·The Journal of Organic Chemistry·Dustin S SiegelMohammad Movassaghi
Sep 24, 2011·Chemical Research in Toxicology·Kathryn E PietschShana J Sturla
Mar 9, 2002·Breast Cancer Research and Treatment·Maryanne C S HerzigJan M Woynarowski
Dec 22, 1999·British Journal of Haematology·P JagadeeswaranD Troyer
Aug 26, 2000·Journal of Pediatric Hematology/oncology·S WeitmanD Von Hoff
Sep 14, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·E S van LaarS J Waters
Mar 9, 2012·BMC Complementary and Alternative Medicine·Veeramuthu DuraipandiyanChinnasamy Muthukumar
Aug 14, 2002·American Journal of Pharmacogenomics : Genomics-related Research in Drug Development and Clinical Practice·D A Anthoney, C J Twelves
Jul 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y SatoK Nakano
Apr 19, 2007·Apoptosis : an International Journal on Programmed Cell Death·Davide CerviaFernando Dini
Jul 28, 1999·Biochemical Pharmacology·M C HerzigJ M Woynarowski
Oct 1, 2006·Expert Opinion on Drug Discovery·Mark J Truty, Raul Urrutia
Nov 2, 2005·Gynecologic Oncology·Michael V SeidenWilliam P McGuire
Nov 1, 2017·Proceedings of the National Academy of Sciences of the United States of America·Stefano MalvezziShana J Sturla
Dec 1, 2005·Pediatric Blood & Cancer·Lisa R BomgaarsSusan M Blaney
Feb 27, 2003·The Oncologist·Francois G el-KamarPeter S Kozuch
Oct 20, 2000·Molecular Pharmacology·J M WoynarowskiP E Juniewicz
Jul 23, 2004·The Journal of Biological Chemistry·Jian WangWeixin Wang
Nov 20, 2016·Chemistry : a European Journal·Stefano MalvezziShana J Sturla
Dec 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S G EckhardtE K Rowinsky
Nov 6, 1998·Molecular Pharmacology·J M WoynarowskiP Juniewicz
May 27, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jérôme AlexandreEsteban Cvitkovic
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Florence KoeppelAnnette K Larsen
Dec 1, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric RaymondEsteban Cvitkovic
Apr 19, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Russell J SchilderJacob Rotmensch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis